Belgium· BE-AMP-SAM664727-00
Evrysdi 5 mg
A risdiplam product containing risdiplam, registered in Belgium by Roche Registration. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Risdiplam is registered in 14 of 19 countries.
Countries holding a registration under ATC M09AX10 (risdiplam), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Risdiplam · ATC M09AX10
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of risdiplam costs, country by country.
Normalised to the WHO defined daily dose (5 mg), the median price runs from $20.14 in France to $872.62 in Switzerland — a ×43 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Risdiplam · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$872.62
- FR France$20.14
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Risdiplam
- Manufacturer
- Roche Registration
- Country
- Belgium (BE)
- ATC code
- M09AX10
- ATC class
- Risdiplam
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb4968566
- be_apb7748627
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for risdiplam.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Risdiplam · interactions on record
2 records
- 2 moderate
Most severe, free to view
- Methylnaltrexone bromideA06AH01moderate
- MetforminA10BA02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Risdiplam in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandEvrysdi
- CzechiaEVRYSDIRoche Registration GmbH, Grenzach-Wyhlen
- SpainEVRYSDI 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULARoche Registration Gmbh
- FinlandEvrysdiRoche Registration GmbH
- FranceEVRYSDI 5 mg, comprimé pelliculéROCHE REGISTRATION (ALLEMAGNE)
- IrelandEvrysdi 5 mg film-coated tabletsRoche Registration GmbH
- IcelandEvrysdiRoche Registration GmbH*
- NetherlandsEvrysdi 5 mg filmomhulde tablettenRoche Registration GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Evrysdi
- Liechtenstein · Evrysdi
- Norway · Evrysdi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b9bec91-691a-470e-9eaf-b260ec63e321 GET /v1/drugs/8b9bec91-691a-470e-9eaf-b260ec63e321?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Evrysdi 5 mg",
"name_fr": "Evrysdi 5 mg",
"name_nl": "Evrysdi 5 mg",
"amp_code": "SAM664727-00",
"strengths": [
"5.0000",
"5.0000"
],
"pack_count": 1,
"substances": [
"Risdiplam",
"Mannitol",
"Sodium Stearyl Fumarate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Risdiplam",
"authorisation_numbers": [
"EU/1/21/1531/002"
]
}See everything about risdiplam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.